A Trial in Stable Intermediate Coronary Lesions and Grey-zone FFR Values
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
In this randomised controlled trial of patients with stable angina and documented
intermediate coronary disease with indeterminate or "grey-zone" Fractional Flow Reserve (FFR)
we will randomise patients to either optimal medical therapy alone versus optimal medical
therapy with PCI and they will be followed up for the primary endpoint of anginal control as
measured by the Seattle Angina Questionnaire at 3 months.